Sophos Biotech S.r.l.

Sophos Biotech S.r.l. is a pharmaceutical startup based in Italy that focuses on the development and distribution of high-quality oncology drugs. The company's founding team comprises industry experts with a wealth of experience in the pharmaceutical sector, dedicated to leveraging their skills to advance scientific knowledge in healthcare. Sophos Biotech is committed to not only bringing forth innovative oncological drugs but also to ensuring their economic viability within the National Health System. The company's approach revolves around facilitating access to top-tier therapies for a broader patient base while upholding the highest standards of quality and safety. Sophos Biotech's portfolio exclusively consists of oncology medications, and the company emphasizes establishing direct communication with healthcare professionals to encourage the appropriate use of drugs, particularly generics. Moreover, the company's mission includes raising awareness about the crucial role generics play in treating severe illnesses such as cancer, highlighting their potential to significantly reduce costs for both the government and patients without compromising efficacy and safety standards.